Why Gosreports research so great？Pompe Disease 2022 research

1
Global Automotive Relay Market Research Report
2016
2
Pompe Disease Pipeline Review, H2 Forecast by
Gosreports 2022 Summary Global Markets
Directs latest Pharmaceutical and Healthcare
disease pipeline guide Pompe Disease Pipeline
Review, H2 2016, provides an overview of the
Pompe Disease (Metabolic Disorders) pipeline
landscape. Pompe disease is an inherited
disorder caused by defect in a gene called GAA.
The GAA gene is responsible for the production of
the GAA enzyme (acid alpha-glucosidase). This
enzyme is needed to break down glycogen, a form
of sugar stored in muscle cells. When too much
glycogen builds up in the muscle cells, the cells
become damaged and the muscles cannot function
properly. Symptoms include respiratory failure,
muscle pain, proximal muscle weakness,
respiratory tract infections, headache and
difficulty chewing or jaw muscle fatigue. Report
Highlights Request for sample of this research
report http//www.gosreports.com/global-automotiv
e-relay-market-worth-13-17-billion-by-2019/
3
Some points from TOC Part I Automotive Relay
Overview Table of Contents Table of Contents
2 List of Tables 5 List of Figures 6 Introduction
7 Global Markets Direct Report Coverage 7 Pompe
Disease Overview 8 Therapeutics Development
9 Pipeline Products for Pompe Disease Overview
9 Pipeline Products for Pompe Disease
Comparative Analysis 10 Pompe Disease
Therapeutics under Development by Companies
11 Pompe Disease Therapeutics under
Investigation by Universities/Institutes 12 Pompe
Disease Pipeline Products Glance 13 Late Stage
Products 13 Clinical Stage Products 14 Early
Stage Products 15 Pompe Disease Products under
Development by Companies 16 Pompe Disease
Products under Investigation by
Universities/Institutes 17 Pompe Disease
Companies Involved in Therapeutics Development 18
4
Some points from TOC Audentes Therapeutics,
Inc. 20 EpiVax, Inc. 21 Etubics Corporation
22 Genzyme Corporation 23 greenovation Biotech
GmbH 24 Oxyrane Belgium NV 25 Pharming Group N.V.
26 RespireRx Pharmaceuticals Inc. 27 Sarepta
Therapeutics, Inc. 28 Pompe Disease
Therapeutics Assessment 29 Assessment by
Monotherapy Products 29 Assessment by Combination
Products 30 Assessment by Target 31 Assessment by
Mechanism of Action 33 Assessment by Route of
Administration 35 Assessment by Molecule Type
37 Drug Profiles 39 Antisense Oligonucleotide to
Activate Lysosomal Alpha-Glucosidase for Pompe
Disease Drug Profile 39
5
Product Description 39 Mechanism Of Action 39 RD
Progress 39 AT-982 Drug Profile 40 Product
Description 40 Mechanism Of Action 40 RD
Progress 40 ATB-200 miglustat Drug Profile
42 Product Description 42 Mechanism Of Action
42 RD Progress 42 CX-1739 Drug Profile
44 Product Description 44 Mechanism Of Action
44 RD Progress 44 CX-717 Drug Profile
48 Product Description 48 Mechanism Of Action
48 RD Progress 48 Gene Therapy 1 to Activate
Acid Alpha-Glucosidase for Pompe Disease Drug
Profile 50
6
Product Description 50 Mechanism Of Action 50 RD
Progress 50 Gene Therapy 2 to Activate Acid
Alpha-Glucosidase for Pompe Disease Drug
Profile 51 Product Description 51 Mechanism Of
Action 51 RD Progress 51 Gene Therapy to
Activate Acid Alpha-Glucosidase for Pompe Disease
Drug Profile 52 Product Description
52 Mechanism Of Action 52 RD Progress
52 GZ-402666 Drug Profile 53 Product
Description 53 Mechanism Of Action 53 RD
Progress 53 MOSS-GAA Drug Profile 55 Product
Description 55 Mechanism Of Action 55 RD
Progress 55 .....................................
........
7
More related reports http//www.gosreports.com/po
mpe-disease-pipeline-review-h2-2016/ About
GosreportsGos International Inc. is one of the
leading distributors of market research reports
in the world today. We host more than 40,000
research products from the worlds top
publication houses.Our web-based platform offers
an unmatched collection of market research
reports, company reviews, databooks, articles,
periodical publications, databases, and much
more, delivered by the successful and
well-established publishers with whom we are
currently in partnership.Contacts UsJoanna
Executive - International Business and partner
RelationsE-mail info_at_gosreports.com Tel
001-510-400-8520Web http//www.gosreports.com